U.S. Approves Drug That Can Sharply Lower Cholesterol Levels

The drug, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price.











from NYT > Health http://ift.tt/1HYYyBm
via health&fitness